Prognostic significance of the neutrophil to lymphocyte ratio in patients with non-small cell lung cancer: A systemic review and meta-analysis

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 3, 2015, Pages 3098-3106

  Peng, Bin ^a   Wang, Yi Han ^a   Liu, Yong Mei ^a   Ma, Lei Xue ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Neutrophil to lymphocyte ratio; NLR; Non small cell lung cancer; NSCLC; Overall survival; Progress free survival; Treatment response

Indexed keywords

ADENOCARCINOMA; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; DATA EXTRACTION; DISEASE FREE SURVIVAL; HUMAN; KAPLAN MEIER METHOD; META ANALYSIS; NEUTROPHIL LYMPHOCYTE RATIO; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; QUALITY CONTROL; SENSITIVITY ANALYSIS; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW (TOPIC); TREATMENT RESPONSE;

EID: 84929178311     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Siegel R, Ward E, Brawley O and Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61: 212-236.
2. Molina JR, Yang P, Cassivi SD, Schild SE and Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 2008; 83: 584-594.
3. Roxburgh CS and McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 2010; 6: 149-163.
4. Tomita M, Shimizu T, Ayabe T, Yonei A and Onitsuka T. Preoperative neutrophil to lymphocyte ratio as a prognostic predictor after curative resection for non-small cell lung cancer. Anticancer Res 2011; 31: 2995-2998.
5. Lee Y, Kim SH, Han JY, Kim HT, Yun T and Lee JS. Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy. J Cancer Res Clin Oncol 2012; 138: 2009-2016.
6. Kaya V, Yildirim M, Demirpence O, Yildiz M and Yalcin AY. Prognostic significance of basic laboratory methods in non- small-cell-lung cancer. Asian Pac J Cancer Prev 2013; 14: 5473-5476.
7. Kacan T, Babacan NA, Seker M, Yucel B, Bah-ceci A, Eren AA, Eren MF and Kilickap S. Could the Neutrophil to Lymphocyte Ratio be a Poor Prognostic Factor for Non Small Cell Lung Cancers? Asian Pac J Cancer Prev 2014; 15: 2089-2094.
8. Zhou SL, Dai Z, Zhou ZJ, Wang XY, Yang GH, Wang Z, Huang XW, Fan J and Zhou J. Ove-rexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. Hepatology 2012; 56: 2242-2254.
9. Lee S and Margolin K. Tumor-infiltrating lymphocytes in melanoma. Curr Oncol Rep 2012; 14: 468-474.
10. Schwarz EC, Qu B and Hoth M. Calcium, cancer and killing: the role of calcium in killing cancer cells by cytotoxic T lymphocytes and natural killer cells. Biochim Biophys Acta 2013; 1833: 1603-1611.
11. Parmar MK, Torri V and Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998; 17: 2815-2834.
12. Danesh J, Collins R, Appleby P and Peto R. As-sociation of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998; 279: 1477-1482.
13. Sarraf KM, Belcher E, Raevsky E, Nicholson AG, Goldstraw P and Lim E. Neutrophil/lymph-ocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovascul Surg 2009; 137: 425-428.
14. Teramukai S, Kitano T, Kishida Y, Kawahara M, Kubota K, Komuta K, Minato K, Mio T, Fujita Y, Yonei T, Nakano K, Tsuboi M, Shibata K, Furuse K and Fukushima M. Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03. Euro J Cancer 2009; 45: 1950-1958.
15. Cedres S, Torrejon D, Martinez A, Martinez P, Navarro A, Zamora E, Mulet-Margalef N and Felip E. Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer. Clin Transl Oncol 2012; 14: 864-869.
16. Botta C, Barbieri V, Ciliberto D, Rossi A, Rocco D, Addeo R, Staropoli N, Pastina P, Marvaso G, Martellucci I, Guglielmo A, Pirtoli L, Sperlon-gano P, Gridelli C, Caraglia M, Tassone P, Tag-liaferri P and Correale P. Systemic inflammatory status at baseline Unal D, Eroglu C, Kurtul N, Oguz A and Tasdemir A. Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non-small cell lung cancer associated with treatment response and prognosis? Asian Pac J Cancer Prev 2013; 14: 5237-5242.
17. Yao Y, Yuan D, Liu H, Gu X and Song Y. Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy. Cancer Immunology, Immuno-therapy 2013; 62: 471-479.
18. Yildirim M, Yildiz M, Duman E, Goktas S and Kaya V. Prognostic importance of the nutritional status and systemic inflammatory response in non-small cell lung cancer. J B.U.ON. 2013; 18: 728-732.
19. Pinato DJ, Shiner RJ, Seckl MJ, Stebbing J, Sharma R and Mauri FA. Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer. Br J Cancer 2014; 110: 1930-5.
20. Xue TC, Zhang L, Xie XY, Ge NL, Li LX, Zhang BH, Ye SL and Ren ZG. Prognostic Significance of the Neutrophil-to-Lymphocyte Ratio in Pri-mary Liver Cancer: A Meta-Analysis. PLoS One 2014; 9: e96072.
21. Paramanathan A, Saxena A and Morris DL. A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours. Surg Oncol 2014; 23: 31-39.
22. Wislez M, Antoine M, Rabbe N, Gounant V, Poulot V, Lavole A, Fleury-Feith J and Cadranel J. Neutrophils promote aerogenous spread of lung adenocarcinoma with bronchioloalveolar carcinoma features. Clin Cancer Res 2007; 13: 3518-3527.
23. Lissoni P, Brivio F, Fumagalli L, Messina G, Ghezzi V, Frontini L, Giani L, Vaghi M, Ardizzoia A and Gardani GS. Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumors. Int J Biol Markers 2004; 19: 135-140.
24. Eerola AK, Soini Y and Paakko P. A high number of tumor-infiltrating lymphocytes are associated with a small tumor size, low tumor sta-ge, and a favorable prognosis in operated small cell lung carcinoma. Clin Cancer Res 2000; 6: 1875-1881.
25. Eerola AK, Soini Y and Paakko P. Tumour infiltrating lymphocytes in relation to tumour angiogenesis, apoptosis and prognosis in patients with large cell lung carcinoma. Lung Cancer 1999; 26: 73-83.